Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2047 of 5804
-
Mini-Tumor biobank could revolutionize cancer drug testing
Knowledge-focused CompletedRecently, oncology has moved to a new clinical practice, more personalized, called Predictive Oncology (PO). PO comes from our knowledge about tumor heterogeneity that implies that each disease, thus each patient, is unique. PO's goal is to identify and administrate the right tr…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New contrast dye could sharpen brain scans
Diagnosis CompletedThis trial aimed to evaluate the Efficacy and Safety of gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Can Long-Acting injections stop stimulant psychosis from worsening?
Disease control CompletedIn Hong Kong, less than 5% of stimulants abusers were reported to misuse these substances via injection. Also, it is well known that patients with co-morbid substance abuse/dependence and psychosis or schizophrenia-related disorders are prone to earlier treatment discontinuation …
Phase: PHASE2, PHASE3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New algorithm could spare cancer patients unnecessary CT scans for blood clots
Diagnosis CompletedThe aim of this study is to prospectively validate the safety and efficiency of management according to the YEARS algorithm to safely rule out clinically suspected PE in patients with active malignancy to be compared with 'standard' management by computed tomography pulmonary ang…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Can computer brain games boost Real-Life skills in early psychosis?
Knowledge-focused TerminatedCognitive remediation (CR) is an evidence-based behavioral skills intervention that targets the cognitive processes underlying functioning in everyday life. It can be used as part of early intervention to reduce cognitive deficits evident at the first episode of psychosis, and ha…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a quicker MRI spot breast cancer sooner? new study recruits 400 High-Risk women
Diagnosis Recruiting nowThis study is aimed to establish a registry of women undergoing intensive surveillance for the early detection of breast cancer in high-risk women.
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New algorithm aims to personalize stroke rehab and speed recovery
Knowledge-focused CompletedStroke is a worldwide major cause of disability with great social and economic burdens. The recovery of motor function is crucial for the patient to regain independence and quality of life. Identifying early predictors of motor recovery and outcomes is useful for planning persona…
Phase: NA • Sponsor: University Hospital of Ferrara • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Chemotherapy drug paclitaxel tested for Hard-to-Treat GIST
Disease control CompletedWith the development of KIT mutation and KIT tyrosine kinase inhibitor imatinib (GlivecTM, Novartis), survival of patients with advanced and/or metastatic gastrointestinal stromal tumor (GIST) has significantly improved. Recently, sunitinib (SuteneTM, Pfizer) and regorafenib (Sti…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a new drug stop mood crashes after estrogen withdrawal?
Disease control CompletedBackground: Our previous studies have found that women who had depression during the perimenopause may have mood symptoms again if they stop estrogen therapy. Estrogen acts in the brain and other tissues by binding to estrogen receptors. There are two main types of estrogen rece…
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Jun 26, 2026 18:06 UTC
-
Parent coaching may help teens keep weight off
Disease control CompletedA randomized control trial to compare the efficacy of two distinct parent treatments on weight loss maintenance for adolescents with obesity participating in a lifestyle intervention including nutrition education, exercise and behavioral support. Funding support from NIH via 1R0…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy shows promise in advanced cancer trial
Disease control CompletedThis study will determine the pharmacodynamically-active dose of gevokizumab and the tolerable dose of gevokizumab in combination with the standard of care anti-cancer therapy in patients with metastatic colorectal cancer, metastatic gastroesophageal cancer and metastatic renal c…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood cell test aims to spot lung cancer sooner
Diagnosis TerminatedPrimary Objective Determine the prevalence of CAMLS in patients with pulmonary nodules. Secondary Objectives Determine the positive and negative predictive value of CAMLS in patients with pulmonary nodules who undergo biopsy. Model combinations of clinical factors with the pres…
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Lab-Grown 3D tumors could help pick the right chemo for blood cancer patients
Knowledge-focused OngoingThe objective of this project is to compare chemosensitivity between chemotherapy combinations in bone marrow aspirates using 3D organoid models. The investigators overarching hypothesis is that 3D organoids are ideal to test chemosensitivity in real time, to provide personalized…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain scans aim to unlock secrets of spinal cord stimulation for chronic pain
Knowledge-focused Recruiting nowSpinal cord stimulation (SCS) relies on stimulation of pain-relieving pathways in the spinal cord to treat chronic neuropathic pain. Traditional paresthesia-based SCS (PB-SCS) relies on providing analgesia through stimulation of spinal cord dorsal columns but it is often associat…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Keytruda after chemo shows promise in Hard-to-Treat ovarian cancer
Disease control CompletedThe overall aim of the study is to demonstrate a clinically meaningful extension of progression free survival using maintenance pembrolizumab. The aim of the translational research is to study the immune microenvironment before and during pembrolizumab therapy.
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Heart screening study reveals hidden amyloidosis in minorities
Diagnosis CompletedIn this study, the investigators recruited a cohort of elderly Black and Hispanic patients with heart failure to define the number of patients who have cardiac amyloidosis by utilizing highly sensitive heart imaging and blood tests. The investigators also explored differences in …
Sponsor: Mathew S. Maurer, MD • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Study tests if starting stronger drugs earlier tames psoriatic arthritis
Disease control CompletedSPEED is a three arm interventional trial nested within a cohort (Trials Within Cohorts or TWiCs design). This tests more aggressive early therapy in patients newly diagnosed with moderate to severe PsA. Arm 1 will receive standard step up therapy in the cohort and act as the con…
Phase: PHASE4 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New cream may ease skin complications after stem cell transplant
Disease control OngoingThe purpose of this study is to compare the safety and effects of ruxolitinib 1.5% cream with those of standard moisturizers in people with non-sclerotic chronic cutaneous GVHD.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a sedative drug extend pain relief after knee surgery?
Symptom relief CompletedIntravenous dexmedetomidine is a drug used in reanimation with sedative, anxiolytic and sympatholytic properties. Recent studies showed useful properties for anaesthesia : decrease of morphine consumption after a various type of surgery, sedative effect on patients under regional…
Phase: PHASE3 • Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New hope for myelofibrosis patients who failed standard therapy?
Disease control TerminatedThis is a phase II, open label, prospective, single-arm study evaluating the efficacy and safety of selinexor in patients with PMF or secondary MF (PPV-MF or PET-MF) who are refractory or intolerant to ruxolitinib and/or any other experimental JAK1/2 inhibitors.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC